Hyatt Hotels

H · NYSE

$176.15+$4.20 (+2.44%)TodayMarket closed ·
Prev close $171.95

H analyst rating

BuyConsensus of 16 analysts over the last 12 months. 69% rate it a buy.
  • Strong buy0
  • Buy11
  • Hold5
  • Underperform0
  • Sell0

12-month price target · 27 analysts

Average $198.08 (+12.5% upside)

Low
$166.65
Now
$176.15
High
$232.05

Upgrades and downgrades

The latest rating actions, newest first

H analyst upgrades, downgrades and rating actions
FirmDateActionRating
Wells FargoOct 19, 2026MaintainsEqual-Weight
BarclaysOct 16, 2026MaintainsOverweight
Freedom BrokerOct 14, 2026InitiatesBuy
SusquehannaOct 13, 2026MaintainsNeutral
Morgan StanleyOct 12, 2026MaintainsOverweight
MizuhoOct 8, 2026MaintainsOutperform
Truist SecuritiesSep 10, 2026MaintainsBuy
Wolfe ResearchSep 2, 2026InitiatesOutperform
Morgan StanleyAug 18, 2026MaintainsOverweight
SusquehannaAug 11, 2026MaintainsNeutral

The case for and against

Updated Oct 14, 2026

Bull case

Hyatt Hotels is well positioned for fundamental improvement because it has become more asset-light while executing effectively on both divestitures and acquisitions, including Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. Its portfolio is diversified across about 35 upscale luxury brands, with 98% of rooms managed and franchised and only 2% owned, supporting higher capital efficiency and more scalable earnings. The positive outlook is also reinforced by broad geographic exposure, with 45% of rooms in the US, 31% in the rest of the world, and 24% in Asia-Pacific, which should help sustain growth across multiple demand channels.

Bear case

Hyatt Hotels is viewed negatively because its fee-driven model still faces meaningful execution risk after acquisitions such as Two Roads Hospitality in 2018 and Apple Leisure Group in 2021, while management itself guided 3Q EBITDA of about $275-280 million, below the $306 million consensus and implying a steep 4Q rebound is needed to hit the low end of the 2026 EBITDA range of $1.155-1.205 billion. Although 2Q26 EBITDA of $297 million beat estimates by 2% and systemwide RevPAR rose 5.9%, the company still lowered the growth outlook only modestly to 3.5-4.5% for 2026, which suggests decelerating momentum and limited room for error. The business remains exposed to macro and regional volatility with 45% of rooms in the US, 31% in the rest of the world, and 24% in Asia-Pacific, while the 14.1% FFO/debt ratio is above the 11.0% downgrade threshold but is expected to deteriorate, reinforcing caution on credit quality.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.